Entinostat in patients with relapsed or refractory abdominal neuroendocrine tumors

K. Jamison, Jacob; Zhou, Mengxi; P. Gelmann, Edward; Luk, Lyndon; E. Bates, Susan; Califano, Andrea; Fojo, Tito

doi:10.1093/oncolo/oyae118

Public

Entinostat in patients with relapsed or refractory abdominal neuroendocrine tumors

Published in The Oncologist • May 31, 2024

Authors:

Jacob K. Jamison

Mengxi Zhou

Edward P. Gelmann

Abstract

BACKGROUND: Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are rare neoplasms with an increasing annual incidence and prevalence. Many are metastatic at presentation or recur following surgical resection and require systemic therapy, for which somatostatin analogs such as octreotide or lanr...

Subject

Refractory (planetary science)

Neuroendocrine tumors

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!